AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Impact of Highly Effective Modulator Therapy on the Cystic Fibrosis Microbiome

Recruitingn/aAges 18 Years - 99 YearsAllDartmouth-Hitchcock Medical Center
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The goal of this observational study is to learn about the effects of a specific cystic fibrosis therapy (Cystic Fibrosis Transmembrane Conductance Regulator Modulator Therapy) on chronic sinonasal disease. The main questions it aims to answer are: 1. How does this therapy impact bacterial communities in the paranasal sinuses? 2. How does this therapy impact inflammation in the paranasal sinuses and olfactory cleft? 3. How does this therapy impact sense of smell and sinonasal disease burden in individuals with cystic fibrosis? 4. How does this therapy impact disease-specific and general quality of life of individuals with cystic fibrosis? Participants will be asked to provide samples from their nose, complete testing of their sense of smell, and complete surveys about their quality of life and sense of smell in this study. Researchers will compare study results between patients who ar

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Subjects between the ages of 18 years old (inclusive) and 99 years old (inclusive) * English-speaking * Diagnosed with CF as established by genetic testing combined with clinical assessment and/or sweat chloride * Patients being seen at the New Hampshire Cystic Fibrosis Center * Adults able to sign informed consent Exclusion Criteria: * Adults unable to consent * Individuals who are not yet adults * Prisoners
๐Ÿ’Š

What it tests

  • Nasal endoscopy with microbiome swab and mucus collection through filter paper and sponge
  • Olfactory Function Testing
  • Survey Completion
๐Ÿ“

Where

1 site
Dartmouth-Hitchcock Medical Center
Lebanon, United States
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy